KDR and breast carcinoma: VEGFR-2 was found to be present in the following cancers: lung cancer, breast cancer, glioblastoma, gastrointestinal cancer, hepatocellular carcinoma, renal cell carcinoma, bladder carcinoma, and osteosarcoma [6].